Tissue equivalency of phantom materials for neutron dosimetry in proton therapy

Medical Physics

Volumn 36, Issue 12, 2009, Pages 5412-5419

  Dowdell, Stephen ^a   Clasie, Ben ^b   Wroe, Andrew ^a,c   Guatelli, Susanna ^a,d   Metcalfe, Peter ^a   Schulte, Reinhard ^c   Rosenfeld, Anatoly ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

Monte Carlo; Proton therapy; Secondary neutrons

Indexed keywords

DOSIMETRY; HISTOLOGY; MONTE CARLO METHODS; NEUTRONS; PHANTOMS; PROTON BEAM THERAPY; PROTON BEAMS;

ABSORBED DOSE; ADIPOSE TISSUE; DOSE EQUIVALENT; HUMAN TISSUES; NEUTRON DOSIMETRY; PHANTOM MATERIALS; PROTON THERAPY; SECONDARY NEUTRONS;

TISSUE;

PLASTIC; POLY(METHYL METHACRYLATE); TISSUE EQUIVALENT PLASTIC; UNCLASSIFIED DRUG; WATER;

ADIPOSE TISSUE; ARTICLE; BRAIN TISSUE; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MATERIALS; MONTE CARLO METHOD; MUSCLE TISSUE; NEUTRON; NEUTRON DOSIMETRY; PHANTOM; PRIORITY JOURNAL; PROTON THERAPY; RADIATION ABSORPTION; RADIATION DOSE; SIMULATION;

EID: 72049095540     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3250857     Document Type: Article

References (33)

1. H. Paganetti, " Nuclear interactions in proton therapy: Dose and relative biological effect distributions originating from primary and secondary particles.," Phys. Med. Biol. 0031-9155 47, 747-764 (2002). 10.1088/0031-9155/47/5/305 (Pubitemid 34232664)
2. E. J. Hall, " Intensity-modulated radiation therapy, protons, and the risk of second cancers.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 65, 1-7 (2006). 10.1016/j.ijrobp.2006.01.027
3. W. H. St Clair, " Advantage of protons compared to conventional x-ray or IMRT in the treatment of a pediatric patient with medulloblastoma., " Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 58, 727-734 (2004). 10.1016/S0360-3016(03)01574-8 (Pubitemid 38221128)
4. R. Miralbell, " Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 54, 824-829 (2002). 10.1016/S0360-3016(02)02982-6
5. C. T. Lee, " Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: How do protons compare with other conformal techniques?," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 63, 362-372 (2005). 10.1016/j.ijrobp.2005.05.061
6. S. M. MacDonald, " Proton radiotherapy for childhood ependymoma: Initial clinical outcomes and dose comparisons.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 71, 979-986 (2008). 10.1016/j.ijrobp.2007.11.065
7. B. G. Baumert, " Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 60, 1314-1324 (2004). 10.1016/j.ijrobp.2004.06.212
8. A. Bolsi, A. Fogliata, and L. Cozzi, " Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: A treatment planning study.," Radiother. Oncol. 0167-8140 68, 1-14 (2003). 10.1016/S0167-8140(03)00117-8 (Pubitemid 37289330)
9. L. Feuvret, " A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 69, 944-954 (2007). 10.1016/j.ijrobp.2007.07.2326
10. U. Schneider, " Secondary neutron dose during proton therapy using spot scanning.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 53, 244-251 (2002). 10.1016/S0360-3016(01)02826-7 (Pubitemid 34465830)
11. F. Trompier, " Secondary exposure for 73 and 200 MeV proton therapy.," Radiat. Prot. Dosim. 0144-8420 125, 349-354 (2007). 10.1093/rpd/ncm154
12. A. Wroe, A. Rosenfeld, and R. Schulte, " Out-of-field dose equivalents delivered by proton therapy of prostate cancer.," Med. Phys. 0094-2405 34, 3449-3456 (2007). 10.1118/1.2759839 (Pubitemid 47339741)
13. A. Wroe, " Out-of-field dose equivalents delivered by passively scattered therapeutic proton beams for clinically relevant field configurations.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 73, 306-313 (2009). 10.1016/j.ijrobp.2008.09.030
14. X. Yan, " Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field.," Nucl. Instrum. Methods Phys. Res. A 0168-9002 476, 429-434 (2002). 10.1016/S0168-9002(01)01483-8 (Pubitemid 33149635)
15. J. Fontenot, " Equivalent dose and effective dose from stray radiation during passively scattered proton radiotherapy for prostate cancer.," Phys. Med. Biol. 0031-9155 53, 1677-1688 (2008). 10.1088/0031-9155/53/6/012
16. M. F. Moyers, " Leakage and scatter radiation from a double scattering based proton beamline.," Med. Phys. 0094-2405 35, 128-144 (2008). 10.1118/1.2805086
17. J. C. Polf, W. D. Newhauser, and U. Titt, " Patient neutron dose equivalent exposures outside of the proton therapy treatment field.," Radiat. Prot. Dosim. 0144-8420 115, 154-158 (2005). 10.1093/rpd/nci264 (Pubitemid 43103402)
18. C. Zacharatou Jarlskog, " Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms.," Phys. Med. Biol. 0031-9155 53, 693-717 (2008). 10.1088/0031-9155/53/3/012
19. ICRP, " Report of the task group on reference man.," International Commission on Radiological Protection, Publication 23 (1975).
20. S. Agostinelli, " Geant4-A simulation toolkit.," Nucl. Instrum. Methods Phys. Res. A 0168-9002 506, 250-303 (2003). 10.1016/S0168-9002(03) 01368-8
21. H. M. Kooy, " Monitor unit calculations for range-modulated spread-out Bragg peak fields.," Phys. Med. Biol. 0031-9155 48, 2797-2808 (2003). 10.1088/0031-9155/48/17/305 (Pubitemid 37121461)
22. G. J. Caporaso, " A compact linac for intensity modulated proton therapy based on a dielectric wall accelerator.," Phys. Med. 24, 98-101 (2008). 10.1016/j.ejmp.2008.01.010 1120-1797
23. ICRU, " The quality factor in radiation protection.," International Commission on Radiation Units and Measurements Report No. 40, 1983.
24. G. Folger, V. N. Ivanchenko, and J. P. Wellisch, " The binary cascade.," Eur. Phys. J. A 1434-6001 21, 407-417 (2004). 10.1140/epja/i2003-10219-7 (Pubitemid 39393275)
25. V. N. Ivanchenko, " Combined cross-sections and elastic scattering.," Proceedings of the 11th Geant4 Collaboration Workshop and Users Conference, Lisbon, Portugal, 2006 (unpublished).
26. K. Amako, " Comparison of Geant4 electromagnetic physics models against the NIST reference data.," IEEE Trans. Nucl. Sci. 0018-9499 52, 910-918 (2005). 10.1109/TNS.2005.852691
27. G. A. P. Cirrone, " Implementation of a new Monte Carlo-GEANT4 simulation tool for the development of a proton therapy beam line and verification of the related dose distributions.," IEEE Trans. Nucl. Sci. 0018-9499 52, 262-265 (2005). 10.1109/TNS.2004.843140 (Pubitemid 40564982)
28. C. Zacharatou Jarlskog and H. Paganetti, " Physics settings for using the Geant4 toolkit in proton therapy.," IEEE Trans. Nucl. Sci. 0018-9499 55, 1018-1025 (2008). 10.1109/TNS.2008.922816
29. physics.nist.gov/PhysRefData/Star/Text/PSTAR.html.
30. ICRP, " Relative biological effectiveness (RBE), quality factor (Q), radiation weighting factor (wR).," International Commission on Radiological Protection Report No. 92, 2003.
31. V. Mares, G. Leuthold, and H. Schraube, " Organ doses and dose equivalents for neutrons above 20 MeV.," Radiat. Prot. Dosim. 0144-8420 70, 391-394 (1997).
32. M. Pelliccioni, " Radiation weighting factors and high energy radiation.," Radiat. Prot. Dosim. 0144-8420 80, 371-378 (1998).
33. ICRU, " Nuclear data for neutron and proton radiotherapy and for radiation protection.," International Commission on Radiation Units and Measurements Report No. 63, 2000.